Brief: Janux Therapeutics Q3 Basic EPS USD -0.39
Nov 06 (Reuters) - Janux Therapeutics Q3 net income USD -24.313 million. Q3 collaboration revenue USD 10 million Q3 operating expenses USD 45.251 million Q3 operating income USD -35.251 million
Nov 06 (Reuters) - Janux Therapeutics Q3 net income USD -24.313 million. Q3 collaboration revenue USD 10 million Q3 operating expenses USD 45.251 million Q3 operating income USD -35.251 million